The Oncology Institute, Inc. TOI Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $147.44M+41.2% | $141.96M+41.6% | $136.56M+36.7% | $119.8M+21.5% | $104.41M+10.3% | ||
| $28.21M+11.2% | $28.04M+12.8% | $25.25M-5.2% | $26.91M-3.5% | $25.38M-10.8% | ||
| $1.62M-9.4% | $1.63M-4.4% | $1.72M+9.5% | $1.81M+18.9% | $1.78M+19.8% | ||
| $153.95M+34.7% | $148.86M+32.7% | $144.62M+27.1% | $131.01M+14.0% | $114.32M+1.5% | ||
| -$6.51M+34.3% | -$6.91M+42.1% | -$8.05M+41.9% | -$11.21M+31.5% | -$9.91M+44.9% | ||
| -4.4%+5.1pp | -4.9%+7.0pp | -5.9%+8.0pp | -9.4%+7.2pp | -9.5%+9.5pp | ||
| $1.93M-65.3% | $1.92M+64.0% | $1.92M-13.7% | $1.87M-11.7% | $5.57M+181% | ||
| $4.02M+142% | -$601K+52.0% | -$8.45M-274% | -$5.93M-770% | -$9.67M-405% | ||
| -$2.49M+87.3% | -$7.51M+43.0% | -$16.5M-2.4% | -$17.14M-10.7% | -$19.59M+1.5% | ||
| $0— | $0— | $0— | -$131K— | $0— | ||
| -$2.49M+87.3% | -$7.51M+43.0% | -$16.5M-2.4% | -$17.01M-9.9% | -$19.59M+1.5% | ||
| -1.7%+17.1pp | -5.3%+7.9pp | -12.1%+4.0pp | -14.2%+1.5pp | -18.8%+2.3pp | ||
| -$0.02+90.5% | -$0.05+66.7% | -$0.14+22.2% | -$0.15+11.8% | -$0.21+4.5% | ||
| -$0.02+90.5% | -$0.05+66.7% | -$0.14+22.2% | -$0.15+11.8% | -$0.21+4.5% | ||
| 101.8M+32.0% | 92.4M+23.1% | 97.5M+29.1% | 93.2M+24.7% | 77.1M+3.9% | ||
| 101.8M+32.0% | 92.4M+23.1% | 97.5M+29.1% | 93.2M+24.7% | 77.1M+3.9% | ||
| $5M+251% | $0-100% | -$5.98M— | -$3.99M-255% | -$3.31M— | ||
| $791K+205% | —— | -$403K-633% | -$19K+83.8% | -$752K-1,206% | ||
| $147.44M+41.2% | $141.96M+41.6% | $136.56M+36.7% | $119.8M+21.5% | $104.41M+10.3% | ||
| -$6.51M+34.3% | -$6.91M+42.1% | -$8.05M+41.9% | -$11.21M+31.5% | -$9.91M+44.9% | ||
| -$4.9M+39.7% | -$5.28M+48.4% | -$6.33M+48.4% | -$9.41M+36.6% | -$8.13M+50.7% | ||
| -$4.9M+39.7% | -$5.28M+48.4% | -$6.33M+48.4% | -$9.41M+36.6% | -$8.13M+50.7% | ||
| -3.3%+4.5pp | -3.7%+6.5pp | -4.6%+7.7pp | -7.9%+7.2pp | -7.8%+9.6pp | ||
| -$6.51M+34.3% | -$6.91M+42.1% | -$8.05M+41.9% | -$11.21M+31.5% | -$9.91M+44.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is The Oncology Institute, Inc.'s revenue?
- The Oncology Institute, Inc. (TOI) generated $545.8M in revenue over the trailing twelve months, up 35.4% year over year.
- Is The Oncology Institute, Inc. profitable?
- The Oncology Institute, Inc. is not currently profitable: it reported a net loss of $43.5M over the trailing twelve months, a -8.0% net margin.
- What is The Oncology Institute, Inc.'s earnings per share?
- The Oncology Institute, Inc.'s diluted EPS over the trailing twelve months is $-0.36.
- Where does The Oncology Institute, Inc.'s income statement data come from?
- Every line is extracted from The Oncology Institute, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
